Attached files

file filename
EX-23.1 - EX-23.1 - ARIAD PHARMACEUTICALS INCd862791dex231.htm
EX-31.2 - EX-31.2 - ARIAD PHARMACEUTICALS INCd862791dex312.htm
EX-31.1 - EX-31.1 - ARIAD PHARMACEUTICALS INCd862791dex311.htm
EX-21.1 - EX-21.1 - ARIAD PHARMACEUTICALS INCd862791dex211.htm
EX-10.16 - EX-10.16 - ARIAD PHARMACEUTICALS INCd862791dex1016.htm
EX-10.9.1 - EX-10.9.1 - ARIAD PHARMACEUTICALS INCd862791dex1091.htm
EX-10.9.2 - EX-10.9.2 - ARIAD PHARMACEUTICALS INCd862791dex1092.htm
EXCEL - IDEA: XBRL DOCUMENT - ARIAD PHARMACEUTICALS INCFinancial_Report.xls
10-K - FORM 10-K - ARIAD PHARMACEUTICALS INCd862791d10k.htm
EX-10.8 - EX-10.8 - ARIAD PHARMACEUTICALS INCd862791dex108.htm

EXHIBIT 32.1

CERTIFICATION

PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

(Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code)

Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), each of the undersigned officers of ARIAD Pharmaceuticals, Inc., a Delaware corporation (the “Company”), does hereby certify, to such officer’s knowledge, that:

The Annual Report on Form 10-K for the year ended December 31, 2014 (the “Form 10-K”) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and the information contained in the Form 10-K fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Dated: March 2, 2015

/s/ Harvey J. Berger, M.D.

Harvey J. Berger, M.D.
Chairman of the Board of Directors,
Chief Executive Officer and President
Dated: March 2, 2015

/s/ Edward M. Fitzgerald

Edward M. Fitzgerald
Executive Vice President,
Chief Financial Officer and Treasurer